Errors in modeling misrepresent the utility of the enhanced liver fibrosis test in the management of non-alcoholic fatty liver disease

J Hepatol. 2020 Dec;73(6):1580-1581. doi: 10.1016/j.jhep.2020.07.009. Epub 2020 Sep 28.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Fibrosis
  • Humans
  • Liver Cirrhosis / diagnosis
  • Liver Function Tests
  • Non-alcoholic Fatty Liver Disease* / diagnosis
  • Non-alcoholic Fatty Liver Disease* / therapy